Frank Sands's LLY Position Overview
Frank Sands (via Sands Capital Management, LLC) currently holds 32,887 shares of Eli Lilly and Company (LLY) worth $30.25 M, representing 0.12% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Frank Sands has initiated a new position in LLY, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Frank Sands's Eli Lilly and Company (LLY) Holding Value Over Time
Track share changes against reported price movement
Quarterly Eli Lilly and Company (LLY) Trades by Frank Sands
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +32,887 | New Buy | 32,887 | $919.77 |
Frank Sands's Eli Lilly and Company Investment FAQs
Frank Sands first purchased Eli Lilly and Company (LLY) in Q1 2026, acquiring 32,887 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Frank Sands has held Eli Lilly and Company (LLY) for 1 quarters since Q1 2026.
Frank Sands's largest addition to Eli Lilly and Company (LLY) was in Q1 2026, adding 32,887 shares worth $30.25 M.
According to the latest 13F filing for Q1 2026, Frank Sands's firm, Sands Capital Management, LLC, owns 32,887 shares of Eli Lilly and Company (LLY), valued at approximately $30.25 M.
As of the Q1 2026 filing, Eli Lilly and Company (LLY) represents approximately 0.12% of Frank Sands's publicly disclosed stock portfolio, making it one of their key holdings.
Frank Sands's peak holding in Eli Lilly and Company (LLY) was 32,887 shares, as reported at the end of Q1 2026.